Comparative Evaluation Between the RealStar Pneumocystis jirovecii PCR Kit and the AmpliSens Pneumocystis jirovecii (carinii)-FRT PCR Kit for Detecting P. jirovecii in Non-HIV Immunocompromised Patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Real-time PCR is more sensitive than microscopic examination for detecting Pneumocystis jirovecii. We compared the performance of two assays for detecting P. jirovecii DNA: the RealStar Pneumocystis jirovecii PCR Kit 1.0 CE (Altona Diagnostics, Hamburg, Germany) and the AmpliSens Pneumocystis jirovecii (carinii)-FRT PCR kit (InterLabService Ltd., Moscow, Russia). Methods: We used 159 samples from the lower respiratory tract (112 bronchoalveolar lavage [BAL] fluid, 37 sputum, and 10 endotracheal aspirate [ETA] samples) of non-HIV immunocompromised patients. Nested PCR and sequencing were used to resolve discordant results. The performance of the two assays was evaluated according to clinical categories (clinical Pneumocystis pneumonia [PCP], possible PCP, or unlikely PCP) based on clinical and radiological observations. Results: The positive and negative percent agreement values were 100% (95% confidence interval [CI], 85.4–100%) and 96.6% (95% CI, 90.9–98.9%), respectively, and kappa was 0.92 (95% CI, 0.84–0.99). P. jirovecii DNA load was significantly higher in the clinical PCP group than in the other groups (P<0.05). When stratified by sample type, the positive rate for BAL fluids from the clinical PCP group was 100% using either assay, whereas the positive rate for sputum/ETA samples was only 20%. Conclusions: The two assays showed similar diagnostic performance and detected low P. jirovecii burden in BAL fluids. Both assays may be useful as routine methods for detecting P. jirovecii DNA in a clinical laboratory setting, though their results should be interpreted considering sample type.
Abstract
Background: Real-time PCR is more sensitive than microscopic examination for detecting Pneumocystis jirovecii. We compared the performance of two assays for detecting P. jirovecii DNA: the RealStar Pneumocystis jirovecii PCR Kit 1.0 CE (Altona Diagnostics, Hamburg, Germany) and the AmpliSens Pneumocystis jirovecii (carinii)-FRT PCR kit (InterLabService Ltd., Moscow, Russia). Methods: We used 159 samples from the lower respiratory tract (112 bronchoalveolar lavage [BAL] fluid, 37 sputum, and 10 endotracheal aspirate [ETA] samples) of non-HIV immunocompromised patients. Nested PCR and sequencing were used to resolve discordant results. The performance of the two assays was evaluated according to clinical categories (clinical Pneumocystis pneumonia [PCP], possible PCP, or unlikely PCP) based on clinical and radiological observations. Results: The positive and negative percent agreement values were 100% (95% confidence interval [CI], 85.4–100%) and 96.6% (95% CI, 90.9–98.9%), respectively, and kappa was 0.92 (95% CI, 0.84–0.99). P. jirovecii DNA load was significantly higher in the clinical PCP group than in the other groups (P<0.05). When stratified by sample type, the positive rate for BAL fluids from the clinical PCP group was 100% using either assay, whereas the positive rate for sputum/ETA samples was only 20%. Conclusions: The two assays showed similar diagnostic performance and detected low P. jirovecii burden in BAL fluids. Both assays may be useful as routine methods for detecting P. jirovecii DNA in a clinical laboratory setting, though their results should be interpreted considering sample type.
참고문헌 (27)
- Thomas CF Jr, "Pneumocystis pneumonia", N Engl J Med, 350, pp.2487~2498 (2004)
- White PL, "Diagnosis and management of Pneumocystis jirovecii infection", Expert Rev Anti Infect Ther, 15, pp.435~447 (2017)
- Alanio A, "ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients", J Antimicrob Chemother, 71, pp.2386~2396 (2016)
- Fauchier T, "Detection of Pneumocystis jirovecii by quantitative PCR to differentiate colonization and pneumonia in immunocompromised HIV-positive and HIV-negative patients", J Clin Microbiol, 54, pp.1487~1495 (2016)
- Robert-Gangneux F, "Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR : a 4-year prospective study", J Clin Microbiol, 52, pp.3370~3376 (2014)
- Montesinos I, "Comparison of 2 real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia in human immunodeficiency virus(HIV)and non-HIV immunocompromised patients", Diagn Microbiol Infect Dis, 82, pp.143~147 (2015)
- Botterel F, "Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients", J Clin Microbiol, 50, pp.227~231 (2012)
- Sasso M, "Performances of four real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia", J Clin Microbiol, 54, pp.625~630 (2016)
- Montesinos I, "Evaluation of a new commercial real-time PCR assay for diagnosis of Pneumocystis jirovecii pneumonia and identification of dihydropteroate synthase(DHPS)mutations", Diagn Microbiol Infect Dis, 87, pp.32~36 (2017)
- Guillaud-Saumur T, "Comparison of a commercial real-time PCR assay, RealCycler® PJIR kit, progenie molecular, to an in-house real-time PCR assay for the diagnosis of Pneumocystis jirovecii infections", Diagn Microbiol Infect Dis, 87, pp.335~337 (2017)
- McTaggart LR, "Validation of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR", J Clin Microbiol, 50, pp.1856~1859 (2012)
- "Altona Diagnostics", 2016
- Tia T, "A highly sensitive novel PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveloar lavage specimens from immunocompromised patients", Clin Microbiol Infect, 18, pp.598~603 (2012)
- Cooley L, "Consensus guidelines for diagnosis, prophylaxis and management of jirovecii pneumonia in patients with haematological and solid malignancies, 2014", Intern Med J, 44, pp.1350~1363 (2014)
- Lu Y, "PCR diagnosis of Pneumocystis pneumonia : a bivariate meta-analysis", J Clin Microbiol, 49, pp.4361~4363 (2011)
- Fan LC, "Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia : a bivariate meta-analysis and systematic review", PLoS One, 8, pp.e73099~ (2013)
- Mühlethaler K, "Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients", Eur Respir J, 39, pp.971~978 (2012)
- Hauser PM, "Multicenter, prospective clinical evaluation of respiratory samples from subjects at risk for Pneumocystis jirovecii infection by use of a commercial real-time PCR assay", J Clin Microbiol, 49, pp.1872~1878 (2011)
- Maillet M, "Pneumocystis jirovecii(Pj)quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients", Eur J Clin Microbiol Infect Dis, 33, pp.331~336 (2014)
- Rudramurthy SM, "Reliable differentiation of Pneumocystis pneumonia from Pneumocystis colonisation by quantification of Major Surface Glycoprotein gene using real-time polymerase chain reaction", Mycoses, 61, pp.96~103 (2018)
- Louis M, "Impact of HIV infection status on interpretation of quantitative PCR for detection of Pneumocystis jirovecii", J Clin Microbiol, 53, pp.3870~3875 (2015)
- Matos O, "Effect of oral washes on the diagnosis of Pneumocystis carinii pneumonia with a low parasite burden and on detection of organisms in subclinical infections", Eur J Clin Microbiol Infect Dis, 20, pp.573~575 (2001)
- Samuel CM, "Improved detection of Pneumocystis jirovecii in upper and lower respiratory tract specimens from children with suspected pneumocystis pneumonia using real-time PCR : a prospective study", BMC Infect Dis, 11, pp.329~ (2011)
- Helweg-Larsen J, "Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples", J Clin Microbiol, 36, pp.2068~2072 (1998)
- Chien JY, "Evaluation of the automated Becton Dickinson MAX real-time PCR platform for detection of Pneumocystis jirovecii", Future Microbiol, 12, pp.29~37 (2017)
- Alanio A, "Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients", Clin Microbiol Infect, 17, pp.1531~1537 (2011)
- Nummi M, "Development of a multiplex real-time PCR assay for detection of Mycoplasma pneumoniae, Chlamydia pneumoniae and mutations associated with macrolide resistance in Mycoplasma pneumoniae from respiratory clinical specimens", Springerplus, 4, pp.684~ (2015)